Approved

Links

Harward University

An Anti-Diabetic Formulation with GLUT4 Translocation Elevative and Insulinotrophic Features

https://dataverse.harvard.edu/dataverse/Erdalcanalkoclar

Harward University

An Anti-inflammatory formulation with simultenaous PGE2 / Nf-Kappa B and FMO3 Suppressive Properties

https://dataverse.harvard.edu/dataset.xhtml?persistentId=doi:10.7910/DVN/77FEJB

Harward University

A Pro-Somathropic formulation with GHR Agonistic Activity ; Enhancing IGF-1 mRNA expression via optimized Thyroid function

https://dataverse.harvard.edu/dataset.xhtml?persistentId=doi:10.7910/DVN/92KBPH

Harward University

An Anti-Obesity Formulation that works via elevating PPARy expression and Thermogenin (UCP-1) levels.

https://dataverse.harvard.edu/dataset.xhtml?persistentId=doi:10.7910/DVN/K6WA5I

MIT University

A Pro-Myotrophic Formula Consisting of Steroidal Components which exhibit Partial SARM-like Effects for the Treatment of Geriatric Cachexia

https://wip.mitpress.mit.edu/pub/erdalcanalkoclar-sarm/branch/1/

MIT University

A Topical Anti-Diabetic Formulation with Wound Healing Accelerative Effects

https://wip.mitpress.mit.edu/pub/erdalcanalkoclar-antidiabetic/branch/1/

MIT University

An Antiviral Composition with Novel Anti-Proliferative Mechanism of Action

https://wip.mitpress.mit.edu/pub/erdalcanalkoclar-antiviral/branch/1/

MIT University

A Novel Anti-Inflammatory Formula with FMO3 and Substance P Suppressive Properties

https://wip.mitpress.mit.edu/pub/erdalcanalkoclar-anti-inflammatory/branch/1/

MIT University

A Pro-Dopaminergic Formulation with Selective cAMP Elevating and Dopamine Receptor Proliferation Enhancing Features

https://wip.mitpress.mit.edu/pub/erdalcanalkoclar-dopamine/branch/1/

MIT University

A Pro-Somathropic Formulation with GH and T3 mRNA Expression Enhancement Properties

https://wip.mitpress.mit.edu/pub/erdalcanalkoclar-pro-somathropic/branch/1/

MIT University

An Antiviral Formula with Reverse Transcriptase and DNA Gyrase Suppressive Features

https://wip.mitpress.mit.edu/pub/erdalcanalkoclar-antiviral2/branch/1/

MIT University

A Thyrogenic Formula for the Treatment of Hypothyroidism

https://wip.mitpress.mit.edu/pub/erdalcanalkoclar-thyrogenic/branch/1/

MIT University

An Immunomodulative Formulation with Allergic Reaction Inhibitive Properties

https://wip.mitpress.mit.edu/pub/erdalcanalkoclar-immunomodulation/branch/1/

MIT University

A Myotrophic Formulation for The Treatment of Muscle Weakness and Muscle Loss due to chronic Coma and Stroke

https://wip.mitpress.mit.edu/pub/erdalcanalkoclar-strength/branch/1/

MIT University

A Nootropic Formula for the Treatment of Attention Deficit Disorder

https://wip.mitpress.mit.edu/pub/erdalcanalkoclar-nootropic/branch/1/

MIT University

A Formulation with Tissue Regeneration Enhancing Properties

https://wip.mitpress.mit.edu/pub/erdalcanalkoclar-regeneration/branch/1/

MIT University

An Ergogenic Formulation with Athletic Performance Enhancing Features

https://wip.mitpress.mit.edu/pub/erdalcanalkoclar-athletic-enhancement/branch/1/

MIT University

An Anti-Obesity Formulation with AMPK upregulative and UCP-1 mRNA expression Enhancement Properties

https://wip.mitpress.mit.edu/pub/erdalcanalkoclar-lipolytic/branch/1/

Europen Commission

Cerebrospinal Upregulation of Endogenous Neurotrophics Part 2

https://cordis.europa.eu/article/id/125460-cerebrospinal-upregulation-of-endogenous-neurotrophics-part-2

Europen Commission

A Novel Approach for The Treatment of Viral Diseases - Part 2

https://cordis.europa.eu/article/id/125348-a-novel-approach-for-the-treatment-of-viral-diseases-part-2

Europen Commission

A Novel Approach to Viral Disease Treatment: Direct Reduction of Systemic Viral Load via Semi-Synthetic Flavonol Glycosides

https://cordis.europa.eu/article/id/125347-a-novel-approach-to-viral-disease-treatment-direct-reduction-of-systemic-viral-loadvia-semisy

Europen Commission

An Anti-inflammatory / Analgesic Formulation with Simultaneous FMO3 / Nf-kappa B And PGE-2 Suppression Properties

https://cordis.europa.eu/article/id/125320-an-antiinflammatory-analgesic-formulation-with-simultaneous-fmo3-nfkappa-band-pge2-suppressio

Europen Commission

Cerebrospinal Upregulation of Endogenous Neurotrophics Part 2

https://cordis.europa.eu/article/id/125460-cerebrospinal-upregulation-of-endogenous-neurotrophics-part-2

Europen Commission

Cerebrospinal upregulation of BDNF and NGF expression: A novel treatment for Neuro-Endocrinal Damage originated from Paralysis & Autoimmune Diseases

https://cordis.europa.eu/article/id/125459-cerebrospinal-upregulation-of-bdnf-and-ngf-expression-a-novel-treatment-for-neuroendocrinal-d

Europen Commission

An Anti-inflammatory Formulation with FMO3 Suppressive Abilitites Part 2

https://cordis.europa.eu/article/id/125321-an-antiinflammatory-formulation-with-fmo3-suppressive-abilitites-part-2

Yale University

SEARCH REPORT

https://groups.som.yale.edu/get_file?eid=ee919a545111efb3bdc5bc3d663a400b

National Institutes of Health

NIH BioSketch NIH Biographical Sketch Instructions (PDF)

https://www.ncbi.nlm.nih.gov/myncbi/erdalcanalkoclar/cv/313889/